Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-1B | 18.0 | 94 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | IL-1B | 19.0 | 68 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-1B | 16.0 | 86 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | IL-1B | 38.0 | 81 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | IL-1B | 18.0 | 74 | ||||
RA2159 | 4 | IL-1B | 20.0 | 76 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | IL-1B | 19.0 | 71 | ||||
N2645 | 4 | IL-1B | 17.0 | 57 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | IL-1B | 18.0 | 72 | ||||
RA2708 | 4 | IL-1B | 15.0 | 64 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 20.5 | 64 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 39.0 | 66 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 18.0 | 71 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 17.0 | 85 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 19.0 | 83 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 20.0 | 47 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 48.0 | 87 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 67.0 | 69 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 40.5 | 56 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 82.5 | 60 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 82.5 | 66 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | IL-1B | 57.0 | 58 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-1B | 22.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-1B | 33.0 | 71 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-1B | 28.0 | 81 |